Lichao Yao

842 total citations
30 papers, 587 citations indexed

About

Lichao Yao is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Lichao Yao has authored 30 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Hepatology and 10 papers in Surgery. Recurrent topics in Lichao Yao's work include Liver Disease Diagnosis and Treatment (11 papers), Liver physiology and pathology (8 papers) and MicroRNA in disease regulation (5 papers). Lichao Yao is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver physiology and pathology (8 papers) and MicroRNA in disease regulation (5 papers). Lichao Yao collaborates with scholars based in China. Lichao Yao's co-authors include Yingan Jiang, Pengpeng Deng, Juanjuan Chen, Jinping Zhou, Mengqin Yuan, Zhi‐Gang Tang, Lanjuan Li, Qiuling Zhang, Lun Wu and Zhiyu Xiong and has published in prestigious journals such as Biomaterials, Free Radical Biology and Medicine and Carbohydrate Polymers.

In The Last Decade

Lichao Yao

29 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lichao Yao China 12 160 120 120 120 86 30 587
Rui Deng China 12 177 1.1× 211 1.8× 140 1.2× 152 1.3× 70 0.8× 33 826
Dong Guo China 17 213 1.3× 100 0.8× 72 0.6× 63 0.5× 190 2.2× 21 666
Shibashish Giri Germany 15 142 0.9× 141 1.2× 44 0.4× 105 0.9× 152 1.8× 40 564
Guangping Liang China 19 326 2.0× 98 0.8× 122 1.0× 51 0.4× 171 2.0× 47 906
Zhihe Liu China 16 255 1.6× 79 0.7× 67 0.6× 122 1.0× 67 0.8× 28 618
Radwa A. Mehanna Egypt 17 204 1.3× 101 0.8× 37 0.3× 123 1.0× 53 0.6× 46 663
Ramasatyaveni Geesala United States 12 180 1.1× 62 0.5× 84 0.7× 41 0.3× 54 0.6× 26 475
Jinglin Wang China 12 206 1.3× 103 0.9× 65 0.5× 32 0.3× 23 0.3× 25 533
Kyung-Soo Kim South Korea 14 153 1.0× 172 1.4× 66 0.6× 93 0.8× 23 0.3× 46 671

Countries citing papers authored by Lichao Yao

Since Specialization
Citations

This map shows the geographic impact of Lichao Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichao Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichao Yao more than expected).

Fields of papers citing papers by Lichao Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lichao Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichao Yao. The network helps show where Lichao Yao may publish in the future.

Co-authorship network of co-authors of Lichao Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Lichao Yao. A scholar is included among the top collaborators of Lichao Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lichao Yao. Lichao Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Mengqin, Zhengrong Yin, Zheng Wang, et al.. (2025). Modification of MSCs with aHSCs-targeting peptide pPB for enhanced therapeutic efficacy in liver fibrosis. Biomaterials. 321. 123295–123295. 5 indexed citations
2.
Xiong, Zhiyu, Ping Chen, Zheng Wang, et al.. (2025). Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transfer. Free Radical Biology and Medicine. 231. 163–177. 6 indexed citations
3.
Wang, Zheng, Mengqin Yuan, Lichao Yao, et al.. (2025). Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells. Journal of Nanobiotechnology. 23(1). 222–222. 4 indexed citations
4.
Chen, Ping, Mengqin Yuan, Lichao Yao, et al.. (2024). Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway. Biomedicine & Pharmacotherapy. 171. 116133–116133. 11 indexed citations
5.
Yao, Lichao, et al.. (2023). Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases. Journal of Gastroenterology and Hepatology. 38(7). 1099–1106. 5 indexed citations
6.
Chen, Ping, Lichao Yao, Mengqin Yuan, et al.. (2023). Mitochondrial dysfunction: A promising therapeutic target for liver diseases. Genes & Diseases. 11(3). 101115–101115. 51 indexed citations
7.
Xiong, Zhiyu, Ping Chen, Mengqin Yuan, et al.. (2023). Integrated Bioinformatics and Validation Reveal IFI27 and Its Related Molecules as Potential Identifying Genes in Liver Cirrhosis. Biomolecules. 14(1). 13–13. 8 indexed citations
8.
Yao, Lichao, Mengqin Yuan, Ping Chen, et al.. (2023). Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers. Tissue and Cell. 84. 102198–102198. 5 indexed citations
9.
Yuan, Mengqin, Lichao Yao, Ping Chen, et al.. (2023). Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 5 indexed citations
10.
Yuan, Mengqin, Lichao Yao, Ping Chen, et al.. (2023). Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis. International Immunopharmacology. 125(Pt A). 111134–111134. 17 indexed citations
11.
Yao, Lichao, et al.. (2023). IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 9 indexed citations
12.
Yang, Lian, Fang Xie, Yang Li, et al.. (2023). Chitin-based hydrogel loaded with bFGF and SDF-1 for inducing endogenous mesenchymal stem cells homing to improve stress urinary incontinence. Carbohydrate Polymers. 319. 121144–121144. 16 indexed citations
13.
Wang, Wei, Ying He, Lulu Zhai, et al.. (2022). m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Epigenetics. 17(12). 1738–1752. 24 indexed citations
14.
Yuan, Mengqin, et al.. (2022). Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease. Stem Cell Research & Therapy. 13(1). 179–179. 56 indexed citations
15.
16.
Yuan, Mengqin, et al.. (2022). Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis. Frontiers in Molecular Biosciences. 9. 1010160–1010160. 7 indexed citations
17.
Yao, Lichao, et al.. (2022). Mesenchymal stromal cells: promising treatment for liver cirrhosis. Stem Cell Research & Therapy. 13(1). 308–308. 40 indexed citations
18.
Deng, Pengpeng, Lichao Yao, Juanjuan Chen, Zhi‐Gang Tang, & Jinping Zhou. (2021). Chitosan-based hydrogels with injectable, self-healing and antibacterial properties for wound healing. Carbohydrate Polymers. 276. 118718–118718. 138 indexed citations
19.
Deng, Pengpeng, Juanjuan Chen, Lichao Yao, Pingan Zhang, & Jinping Zhou. (2021). Thymine-modified chitosan with broad-spectrum antimicrobial activities for wound healing. Carbohydrate Polymers. 257. 117630–117630. 49 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rui Deng Breakdown of academic impact, for papers by Dong Guo Breakdown of academic impact, for papers by Shibashish Giri Breakdown of academic impact, for papers by Guangping Liang Breakdown of academic impact, for papers by Zhihe Liu Breakdown of academic impact, for papers by Radwa A. Mehanna Breakdown of academic impact, for papers by Ramasatyaveni Geesala Breakdown of academic impact, for papers by Jinglin Wang Breakdown of academic impact, for papers by Kyung-Soo Kim
Rankless by CCL
2026